title: Exploring the ameliorative potential of probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on dextran sodium sulphate induced colitis in mice.
abstract: Conventional medical therapies for ulcerative colitis (UC) are still limited due to the adverse side effects like dose-dependent diarrhoea and insufficient potency to keep in remission for long-term periods. So, new alternatives that provide more effective and safe therapies for ulcerative colitis are constantly being sought. In the present study, probiotic LaBb Dahi was selected for investigation of its therapeutic effect on DSS-induced colitis model in mice. LaBb Dahi was prepared by co-culturing Dahi culture of Lactococci along with selected strain of Lactobacillus acidophilus LaVK2 and Bifidobacterium bifidum BbVK3 in buffalo milk. Four groups of mice (12 each) were fed for 17 d with buffalo milk (normal control), buffalo milk plus DSS (Colitis control), Dahi plus DSS, and LaBb Dahi plus DSS, respectively, with basal diet. The disease activity scores, weight loss, organ weight, colon length, myeloperoxidase (MPO) and β-glucoronidase activity was assessed, and the histopathological picture of the colon of mice was studied. All colitis control mice evidenced significant increase in MPO, β-glucoronidase activity and showed high disease activity scores along with histological damage to colonic tissue. Feeding with LaBb Dahi offered significant reduction in MPO activity, β-glucoronidase activity and improved disease activity scores. We found significant decline in length of colon, organ weight and body weight in colitis induced controls which were improved significantly by feeding LaBb Dahi. The present study suggests that LaBb Dahi can be used as a potential nutraceutical intervention to combat UC related changes and may offer effective adjunctive treatment for management of UC.
authors: Animal Biochemistry Division, National Dairy Research Institute, Karnal-132001, Haryana, India. drsagarndri@gmail.com
authors: Sagar R
authors: SR
authors: Jadhav
authors: Umesh Kr
authors: UK
authors: Shandilya
authors: Vinod K
authors: VK
authors: Kansal
mesh_terms: D000818:Animals; D001644:Bifidobacterium; D001835:Body Weight; D002020:Buffaloes; D003093:Colitis, Ulcerative / Q000139:chemically induced / Q000473:pathology / Q000628:therapy*; D003106:Colon / Q000473:pathology; D016264:Dextran Sulfate; D019587:Dietary Supplements; D004195:Disease Models, Animal; D005966:Glucuronidase / Q000378:metabolism; D007779:Lactobacillus acidophilus; D008297:Male; D051379:Mice; D008892:Milk / Q000382:microbiology; D009195:Peroxidase / Q000378:metabolism; D019936:Probiotics / Q000627:therapeutic use*
chemical_list: D016264:Dextran Sulfate; D009195:Peroxidase; D005966:Glucuronidase